A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...

Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, depression, type 2 diabetes, and prostate cancer less ...

Researchers have found that gut bacteria can interfere with the effectiveness of over 400 commonly used medications that ...

Common gut bacteria may interfere with the effectiveness of widely used medications for conditions such as migraines, depression, type 2 diabetes, and prostate cancer, a new study has revealed.

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University , shows how common gut ...

About Domain Therapeutics Domain Therapeutics is a clinical-stage biopharmaceutical company developing highly differentiated therapeutic strategies targeting G protein-coupled receptors (GPCRs), a ...

G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand – which can range from small molecules like cyclic AMP to ...

STRASBOURG, France, MONTREAL and BOSTON, April 1, 2025 /PRNewswire/ -- Domain Therapeutics ("Domain" or "the Company"), the GPCR experts harnessing deep receptor biology to develop breakthrough ...

A recent study published in Engineering delves into the complex mechanisms of drug addiction, highlighting the crucial role of astrocytic G protein-coupled receptors (GPCRs). This research offers ...